Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2

Journal of Bone and Joint Surgery

Volumn 91, Issue 5, 2009, Pages 1181-1189

  Burkus, J Kenneth ^a   Gornet, Matthew F ^b   Schuler, Thomas C ^c   Kleeman, Thomas J ^d   Zdeblick, Thomas A ^e  

^a HUGHSTON CLINIC   (United States)

^b Spine Research Center   (United States)

^c Virginia Spine Institute   (United States)

^d New Hampshire Neurospine Institute   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; ANTERIOR LUMBAR INTERBODY ARTHRODESIS; ARTHRODESIS; ARTICLE; CLINICAL TRIAL; DISABILITY; ENDOPROSTHESIS LOOSENING; FEMALE; HUMAN; IMPLANT; INTERBODY FUSION CAGE; INTERMETHOD COMPARISON; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK DISEASE; LAPAROSCOPIC SURGERY; LEG PAIN; LOW BACK PAIN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSWESTRY DISABILITY INDEX; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; REOPERATION; SCORING SYSTEM; SHORT FORM 36; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; SPONDYLOLISTHESIS; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ARTHRODESIS; BACK PAIN; BONE MORPHOGENETIC PROTEINS; FEMALE; GELATIN SPONGE, ABSORBABLE; HUMANS; LEG; LUMBAR VERTEBRAE; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REOPERATION; SPONDYLOLISTHESIS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 70350059342     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.G.01485     Document Type: Article

References (26)

1. Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord. 1998;11:95-101.
2. Hecht BP, Fischgrund JS, Herkowitz HN, Penman L, Toth JM, Shirkhoda A. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine. 1999;24:629-636 (Pubitemid 29162904)
3. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine. 2000;25:376-381
4. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech. 2002;15:337-349 (Pubitemid 35403089)
5. Burkus JK, Sandhu HS, Gornet MF, Longley MC. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am. 2005;87:1205-1212
6. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech. 2003;16:113-122 (Pubitemid 36397568)
7. Anand N, Hamilton JF, Perri B, Miraliakbar H, Goldstein T. Cantilever TLIF with structural allograft and RhBMP2 for correction and maintenance of segmental sagittal lordosis: long-term clinical, radiographic, and functional outcome. Spine. 2006;31:E748-53. (Pubitemid 44423517)
8. Kuklo TR, Rosner MK, Polly DW Jr. Computerized tomography evaluation of a resorbable implant after transforaminal lumbar interbody fusion. Neurosurg Focus. 2004;16:E10.
9. Lanman TH, Hopkins TJ. Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly(L-lactide-co-D,L- lactide) bioresorbable implants. Neurosurg Focus. 2004;16:E9.
10. Mummaneni PV, Pan J, Haid RW, Rodts GE. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine. 2004;1:19-23.
11. Potter BK, Freedman BA, Verwiebe EG, Hall JM, Polly DW Jr, Kuklo TR. Transforaminal lumbar interbody fusion: clinical and radiographic results and complications in 100 consecutive patients. J Spinal Disord Tech. 2005;18:337-346
12. Schwender JD, Holly LT, Rouben DP, Foley KT. Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results. J Spinal Disord Tech. 2005;18 Suppl:S1-6.
13. Slosar PJ, Josey R, Reynolds J. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. Spine J. 2007;7:301-307 (Pubitemid 46667736)
14. Villavicencio AT, Burneikiene S, Nelson EL, Bulsara KR, Favors M, Thramann J. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine. 2005;3:436-443
15. Kleeman TJ, Ahn UM, Talbot-Kleeman A. Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes. Spine. 2001;26:2751-2756 (Pubitemid 34019769)
16. Hsu HP, Zanella JM, Peckham SM, Spector M. Comparing ectopic bone growth induced by rhBMP-2 on an absorbable collagen sponge in rat and rabbit models. J Orthop Res. 2006;24:1660-1669 (Pubitemid 44203297)
17. Fairbank JC, Couper J, Davies JB, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66:271-273 (Pubitemid 11234479)
18. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40-66.
19. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483
20. Bagby G. The Bagby and Kuslich (BAK) method of lumbar interbody fusion. Spine. 1999;24:1857.
21. Brantigan JW, Neidre A, Toohey JS. The Lumbar I/F Cage for posterior lumbar interbody fusion with the variable screw placement system: 10-year results of a Food and Drug Administration clinical trial. Spine J. 2004;4:681-688 (Pubitemid 39497289)
22. Button G, Gupta M, Barrett C, Cammack P, Benson D. Three- to six-year follow-up of stand-alone BAK cages implanted by a single surgeon. Spine J. 2005;5:155-160 (Pubitemid 40331435)
23. Kuslich SD, Danielson G, Dowdle JD, Sherman J, Fredrickson B, Yuan H, Griffith SL. Four-year follow-up results of lumbar spine arthrodesis using the Bagby and Kuslich lumbar fusion cage. Spine. 2000;25:2656-2662 (Pubitemid 30818337)
24. Kuslich SD, Ulstrom CL, Griffith SL, Ahern JW, Dowdle JD. The Bagby and Kuslich method of lumbar interbody fusion. History, techniques, and 2-year follow-up results of a United States prospective, multicenter trial. Spine. 1998;23:1267-1279
25. Martin BI, Mirza SK, Comstock BA, Gray DT, Kreuter W, Deyo RA. Are lumbar spine reoperation rates falling with greater use of fusion surgery and new surgical technology? Spine. 2007;32:2119-2126
26. Kornblum MB, Fischgrund JS, Herkowitz HN, Abraham DA, Berkower DL, Ditkoff JS. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective long-term study comparing fusion and pseudarthrosis. Spine. 2004;29:726-734